JP Stock MarketDetailed Quotes

4594 BrightPath Biotherapeutics

Watchlist

53
-3-5.36%

20min DelayMarket Closed Sep 6 15:00 JST

4.25BMarket Cap-2910P/E (Static)

BrightPath Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:JPY

2024/FY

Stock NameRevenueRatio

Drug development business72K100.00%

Region Currency:JPY

2024/FY

Stock NameRevenueRatio

Japan72K100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

JP

Overall